Panel Discussion: Beyond Compliance: Building a Proactive Drug Safety Culture
How leading organisations are embedding pharmacovigilance into decision-making, culture, and strategy - moving from reactive compliance to proactive patient safety.
- How can pharmacovigilance move from a compliance function to a strategic driver of patient safety?
- What does true cross-functional ownership of drug safety look like in practice?
- Are current KPIs driving the right behaviours or just ticking boxes?
- How can leadership create accountability for proactive safety decisions?